cannabinol (INM-755) / InMed Pharma - LARVOL DELTA

A SUCTION BLISTER MODEL TO CHARACTERIZE EPIDERMAL WOUND HEALING AND EVALUATE THE EFFICACY OF THE TOPICAL WOUND HEALING AGENT INM-755 IN HEALTHY VOLUNTEERS. (PubMed, Eur J Pharm Sci) - "Despite differences from disease-specific blistering, our developed model provides a valuable platform for studying wound healing mechanisms and assessing novel therapeutic interventions. The sensitivity to treatment effects demonstrated in our study underscores the potential utility of this model in early-phase clinical drug development programs targeting wound healing disorders."

Journal

INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa (clinicaltrials.gov) - P2 | N=19 | Completed | Sponsor: InMed Pharmaceuticals Inc. | Active, not recruiting ➔ Completed

Trial completion